Skip to main content
SearchLogin or Signup

Reviews of "SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline"

Reviewers: Samreen Zaidi | 📗📗📗📗◻️ • Roger Dodd (American Red Cross) | 📒📒📒◻️◻️

Published onDec 04, 2020
Reviews of "SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline"

To read the original manuscript, click the link above.

Summary of Reviews: This study cautiously asserts that the outcome of a seroprevalence study is impacted by the declining prevalence rate, which impacts the sensitivity. Reviewers suggest the conclusion is rational and largely justifiable but limited by the data they utilize.

Reviewer 1 (Samreen Zaidi) | 📗📗📗📗◻️

Reviewer 2 (Roger Dodd) | 📒📒📒 ◻️◻️

RR:C19 Strength of Evidence Scale Key

📕 ◻️◻️◻️◻️ = Misleading

📙📙 ◻️◻️◻️ = Not Informative

📒📒📒 ◻️◻️ = Potentially Informative

📗📗📗📗◻️ = Reliable

📘📘📘📘📘 = Strong

To read the reviews, click the links below.

Comments
0
comment

No comments here